Ccc Intelligent Solutions Hld Stock Price, News & Analysis

Clarivate Plc (NYSE:CCC) released the 2020 Pharmaceutical R&D Factbook, highlighting a decrease in global R&D spending to $80 billion in 2022, down from a predicted $86 billion. This marks the first decline since 2016, influenced by COVID-19 and its impact on drug development. Notably, the average drug development time decreased from 14.5 years in 2010 to 10.2 years in 2019. However, new molecular entity (NME) launches have dropped 22% since 2018, with the U.S. seeing a 25% decrease in launches, while China and Japan increased their NME launches by 11% since 2017.

Clarivate Plc (NYSE: CCC) has announced the naming of 24 new Citation Laureates, highlighting researchers whose work is considered 'Nobel class'. This year's honorees come from countries including the USA, Canada, Germany, Japan, South Korea, and the UK. Since 2002, Clarivate has recognized researchers based on citation data from the Web of Science, with only 5,700 papers cited over 2,000 times. To date, 54 Citation Laureates have received a Nobel Prize. Notable mention includes advances in personalized medicine, gender pay gap studies, and galaxy formation.

Clarivate Plc (NYSE: CCC) has released a report detailing indigenous research trends in Australia, New Zealand, and the Pacific Region. It highlights that only over 1% of regional research is indigenous-focused, with a significantly lower citation impact (CNCI of 0.65) compared to global baselines. The report shows New Zealand leads in research volume but not in impact per state. Major contributors include the Universities of Auckland, Sydney, and Otago, with Health, Society, and Culture being the prominent research areas under new FoR classifications. The full report is available for download.

Clarivate Plc (NYSE:CCC) has released a report titled Identifying Research Fronts in the Web of Science, detailing how citation clusters from published papers can pinpoint emerging scientific topics. This report emphasizes the value of modern research evaluation metrics derived from the Web of Science. Key insights include the identification of hot research areas like CRISPR and Machine Learning, which can enhance innovation strategies for researchers and organizations. Dr. Martin Szomszor highlights that these new metrics move beyond traditional performance measures to provide deeper insights into research impact.

Clarivate Plc (NYSE: CCC) has launched the Innovation Exchange, an online platform designed to provide life science, healthcare, and research professionals with access to innovative software and data from approved partners. This platform allows for rapid licensing and deployment of solutions tailored to specific decision-making needs. The Innovation Exchange aims to enhance research, development, and commercialization efforts, incorporating direct licensing options and a suite of applications, including unique datasets related to COVID-19.

Clarivate Plc (NYSE: CCC) announced that Jerre Stead, Executive Chairman and CEO, along with CFO Richard Hanks, will participate in two virtual investor conferences in September 2020. The first event is Citi's 2020 Global Technology Virtual Conference on September 10 at 3:20 PM Eastern Time. The second is Barclays Global Financial Services Conference scheduled for September 16 at 9:00 AM Eastern Time. Both presentations will be available via live webcast and replay on their respective links.

Clarivate has partnered with the Benelux Office for Intellectual Property (BOIP) to enhance trademark research services using AI-driven technology. This advancement makes researching image trademarks more efficient and comprehensive, automating previously time-consuming tasks. The partnership aims to address a growing need, as 40% of trademarks include image components. With trademark filing activity reaching 14.3 million recently, this innovative approach supports BOIP in providing improved services to IP professionals in the region.

Clarivate Plc (NYSE:CCC) and IP DESK have partnered to enhance trademark management efficiency for IP professionals. This collaboration integrates CompuMark's global trademark watching solution into the IP DESK platform, enabling users to access vital trademark data seamlessly. With over 5,500 trademarks filed daily, this partnership aims to safeguard brands and reduce infringement risks. Jeff Roy from Clarivate emphasizes the goal of maximizing value from intellectual property, while Martin Setlak from IP DESK highlights improved customer satisfaction and responsiveness to trademark conflicts.